All stock lists
Unlock the score
ProMIS Neurosciences Inc. (NASDAQ:PMN)
CA · Delayed Price · Currency is USD
Healthcare · Biotechnology
8.20-0.14 (-1.68%)
Market cap
$73.5M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 10, 2007
Website
Insider Score
/ 100
PMN Insider Score
ProMIS Neurosciences Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Financial Health Score
Fair
From PMN’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$42.2M
- Net margin
- —
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $53.4M
- Debt / equity
- 0.00
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $56.7M
- Current liabilities
- $7.2M
- Current ratio
- 7.85
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$42.0M
- Free cash flow
- -$42.0M
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 9.1M
- Share growth (1y)
- 555.8%
- Cash runway
- 15 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PMN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.74 M | 1.67 M | 1.40 M | 1.95 M | 1.43 M | 2.00 M |
| R&D Expense | 9.52 M | 6.97 M | 9.37 M | 9.80 M | 8.75 M | 5.46 M |
| Operating Expenses | 12.27 M | 8.64 M | 10.77 M | 11.75 M | 10.18 M | 7.46 M |
| Operating Income | -12.27 M | -8.64 M | -10.77 M | -11.75 M | -10.18 M | -7.46 M |
| Pretax Income | -11.73 M | -8.24 M | -10.67 M | -11.58 M | -10.12 M | -7.35 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -11.73 M | -8.24 M | -10.67 M | -11.58 M | -10.12 M | -7.35 M |
| EPS (Basic) | -1.28 | -1.26 | -6.08 | -8.27 | -7.25 | -5.25 |
| EPS (Diluted) | -1.28 | -1.26 | -6.08 | -8.27 | -7.25 | -5.25 |
| Shares Outstanding | 9.14 M | 6.53 M | 1.76 M | 1.39 M | 1.39 M | 1.39 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.